Larimar Therapeutics Inc. (NASDAQ: LRMR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LARIMAR THERAPEUTICS INC.

Larimar Therapeutics Inc. (NASDAQ: LRMR)
Listen to this Section


$3.49
-0.0100 ( -0.29% ) 0.5K

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Clinical Trial Pipeline Stages


Drug Name Stage
Nomlabofusp (CTI-1601)DetailsRare genetic disease, Rare diseases, Friedreich’s Ataxia Phase 2
Nomlabofusp (CTI-1601)DetailsRare diseases, Rare genetic disease, Friedreich’s Ataxia Phase 2

Market Data


Open $3.49
Previous Close $3.50
Volume 0.5K
Market Cap $377.10M
Day Range $3.55 - $3.57
52 Week Range $2.72 - $6.42
Shares Outstanding 103.88M
Change % -0.29%
Net Change ▼ -0.0100
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 4,627,968.00

Date Type Amount Purchased Purchaser
2025-08-04 Buy 3387529.00 Flynn James E
2024-06-03 Sale -19000.00 Flynn James E
2024-05-31 Sale -19000.00 THOMAS FRANK E
2024-05-31 Sale -19000.00 SHERMAN JEFFREY W
2024-05-31 Sale -19000.00 Truitt Joseph
2024-05-31 Buy 57208.00 Hamilton Thomas Edward
2024-05-31 Sale -19000.00 LEFF JONATHAN S
2024-02-16 Buy 1430206.00 Flynn James E
2024-02-15 Buy 2000.00 THOMAS FRANK E
2024-01-19 Sale -66125.00 BEN-MAIMON CAROLE

SEC Filings


Form Type Description Pages Date
8-k 8K-related 63 Nov 10, 2025
10-q Quarterly Reports 56 Nov 05, 2025
8-k 8K-related 13 Nov 05, 2025
8-k 8K-related 63 Oct 14, 2025
8-k 8K-related 33 Sep 29, 2025
8-k 8K-related 72 Aug 14, 2025
10-q Quarterly Reports 56 Aug 14, 2025
4 Insider transactions 2 Aug 04, 2025
8-k 8K-related 15 Jul 31, 2025
8-k 8K-related 12 Jul 29, 2025

Latest News